Trial Profile
Effects of Simvastatin and Rosiglitazone Combination in Patients With the Metabolic Syndrome.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary) ; Simvastatin (Primary)
- Indications Metabolic syndrome; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms SIROCO
- 27 Feb 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2012 Results published in Diabetes, Obesity and Metabolism.